Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Depreciation and Depletion (2023 - 2025)

Standard Biotools (LAB) has disclosed Depreciation and Depletion for 3 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Depreciation and Depletion rose 62.5% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.1 million through Dec 2025, up 39.66% year-over-year, with the annual reading at $6.9 million for FY2025, 81.58% up from the prior year.
  • Depreciation and Depletion for Q4 2025 was $1.3 million at Standard Biotools, down from $1.5 million in the prior quarter.
  • The five-year high for Depreciation and Depletion was $3.3 million in Q1 2025, with the low at $700000.0 in Q1 2023.
  • Average Depreciation and Depletion over 3 years is $1.6 million, with a median of $1.3 million recorded in 2025.
  • The sharpest move saw Depreciation and Depletion soared 328.57% in 2024, then rose 10.0% in 2025.
  • Over 3 years, Depreciation and Depletion stood at $700000.0 in 2023, then rose by 14.29% to $800000.0 in 2024, then surged by 62.5% to $1.3 million in 2025.
  • According to Business Quant data, Depreciation and Depletion over the past three periods came in at $1.3 million, $1.5 million, and $2.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.